Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

This study has been completed.

Study NCT00228605 Information provided by Cephalon

First Received: September 27, 2005 Last Updated: November 9, 2007 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Estimated Primary Completion Date:	No date given